AR121663A1 - AUTONOMOUS KNOB DOMAIN PEPTIDES - Google Patents
AUTONOMOUS KNOB DOMAIN PEPTIDESInfo
- Publication number
- AR121663A1 AR121663A1 ARP210100750A ARP210100750A AR121663A1 AR 121663 A1 AR121663 A1 AR 121663A1 AR P210100750 A ARP210100750 A AR P210100750A AR P210100750 A ARP210100750 A AR P210100750A AR 121663 A1 AR121663 A1 AR 121663A1
- Authority
- AR
- Argentina
- Prior art keywords
- autonomous
- antibody fragments
- domain peptides
- knob domain
- isolated antibody
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
La presente descripción se refiere a fragmentos aislados de anticuerpos, en particular a dominios knob aislados de CDR-H3 bovina ultralarga o porciones de la misma que se unen a un antígeno de interés, y formulaciones que comprenden los mismos. La descripción se refiere, además, al uso de formulaciones y fragmentos de anticuerpos aislados en tratamientos. La presente descripción también se extiende a métodos para preparar dichos fragmentos de anticuerpos aislados.The present disclosure relates to isolated antibody fragments, in particular to isolated bovine CDR-H3 ultralong knob domains or portions thereof that bind an antigen of interest, and formulations comprising the same. The description further refers to the use of formulations and isolated antibody fragments in treatments. The present disclosure also extends to methods for preparing such isolated antibody fragments.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004462.4A GB202004462D0 (en) | 2020-03-27 | 2020-03-27 | Antibody fragments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121663A1 true AR121663A1 (en) | 2022-06-29 |
Family
ID=70553376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100750A AR121663A1 (en) | 2020-03-27 | 2021-03-26 | AUTONOMOUS KNOB DOMAIN PEPTIDES |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR121663A1 (en) |
| GB (1) | GB202004462D0 (en) |
-
2020
- 2020-03-27 GB GBGB2004462.4A patent/GB202004462D0/en not_active Ceased
-
2021
- 2021-03-26 AR ARP210100750A patent/AR121663A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB202004462D0 (en) | 2020-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020001974A1 (en) | Anti-trem2 antibodies and methods of using them. (divisional request 201903093) | |
| CO2022015049A2 (en) | Autonomous knob domain peptides | |
| CL2020001619A1 (en) | Anti-cd33 antibodies and methods of using them. (divisional request 201903095) | |
| AR115418A1 (en) | ANTI-SIRPA ANTIBODIES (SIGNAL REGULATING PROTEIN a) AND METHODS OF USE OF THE SAME | |
| CL2022001554A1 (en) | Anti-mertk antibodies and methods of using the same | |
| CL2023001064A1 (en) | Anti-steap1 antigen binding protein | |
| UY37928A (en) | ANTI-CD38 ANTIBODIES AND METHODS OF USE | |
| CL2024002250A1 (en) | Use of anti-vd1 antibody to treat cancer, an infectious disease or an inflammatory disease. | |
| CR20200579A (en) | ANTIBODIES AGAINST ENTPD2, COMBINATION THERAPIES AND METHODS OF USE OF ANTIBODIES AND COMBINATION THERAPIES | |
| CO2021001742A2 (en) | Anti-sortilin antibodies and methods for their use | |
| MX2017012802A (en) | ANTISORTILINE ANTIBODIES AND METHODS FOR USE. | |
| WO2020006374A3 (en) | Anti-sirp-beta1 antibodies and methods of use thereof | |
| CO2021003078A2 (en) | Anti-cd33 antibodies and methods of using them | |
| MX2021011330A (en) | CLAUDIN-6 ANTIBODIES AND DRUG CONJUGATES. | |
| AR122930A1 (en) | PRE-TARGETING ANTIBODIES AND METHODS OF USE | |
| CO2023001559A2 (en) | fgfr3 antibodies and methods of use | |
| BR112022024262A2 (en) | METHODS OF TREATMENT OF IGA NEPHROPATHY WITH AN APRIL-BINDING ANTIBODY | |
| MX2024012474A (en) | Anti-cluster of differentiation 28 (CD28) antibodies and methods of using them | |
| AR121663A1 (en) | AUTONOMOUS KNOB DOMAIN PEPTIDES | |
| BR112023021256A2 (en) | HUMAN ANTIBODIES TO ARTEMINA AND METHODS OF USE THEREOF | |
| MX2023012707A (en) | ANTIBODIES TO THE IMMUNORRECEPTOR PROTEIN OF T CELLS WITH IG AND ITIM DOMAINS (ANTI-TIGIT) AND METHODS OF USE OF THESE. | |
| MX2023008027A (en) | Sialidase-her2-antibody fusion proteins and methods of use thereof. | |
| AR120739A1 (en) | ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF | |
| AR116101A1 (en) | ANTI-STEAP1 ANTIGEN BINDING PROTEIN | |
| AR121129A1 (en) | ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE |